Literature DB >> 20196670

Pseudoneoplastic mimics of prostate and bladder carcinomas.

Omar Hameed1, Peter A Humphrey.   

Abstract

CONTEXT: The differential diagnoses of prostatic carcinoma and bladder epithelial neoplasms include several histologic mimics that should be known to avoid misdiagnosis.
OBJECTIVE: To discuss pseudoneoplastic lesions of the prostate and bladder that could potentially be confused with prostatic carcinoma and bladder epithelial neoplasms, respectively, with specific focus on their distinguishing histopathologic features. DATA SOURCES: Relevant published literature and authors' experience.
CONCLUSIONS: Pseudoneoplastic lesions in the prostate include those of prostatic epithelial origin, the most common being atrophy, adenosis (atypical adenomatous hyperplasia), basal cell hyperplasia, and crowded benign glands, as well as those of nonprostatic origin, such as seminal vesicle epithelium. Such lesions often mimic lower-grade prostatic adenocarcinoma, whereas others, such as clear cell cribriform hyperplasia and granulomatous prostatitis, for example, are in the differential diagnosis of Gleason adenocarcinoma, Gleason grade 4 or 5. Pseudoneoplastic lesions of the urinary bladder include lesions that could potentially be confused with urothelial carcinoma in situ, such as reactive urothelial atypia, and others, such as polypoid/papillary cystitis, where papillary urothelial neoplasms are the main differential diagnostic concern. Several lesions can mimic invasive urothelial carcinoma, including pseudocarcinomatous hyperplasia, von Brunn nests, and nephrogenic adenoma. Diagnostic awareness of the salient histomorphologic and relevant immunohistochemical features of these prostatic and urinary bladder pseudoneoplasms is critical to avoid rendering false-positive diagnoses of malignancy.

Entities:  

Mesh:

Year:  2010        PMID: 20196670     DOI: 10.5858/134.3.427

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.

Authors:  Oluwole Fadare; Vinita Parkash; Katja Gwin; Krisztina Z Hanley; Elke A Jarboe; Sharon X Liang; Charles M Quick; Wenxin Zheng; Kojo R Rawish; Jonathan L Hecht; Mohamed M Desouki
Journal:  Hum Pathol       Date:  2013-10-10       Impact factor: 3.466

2.  The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.

Authors:  Jochen K M Lennerz; Seok-Hyung Kim; Edward L Oates; Won Jae Huh; Jason M Doherty; Xiaolin Tian; Andrew J Bredemeyer; James R Goldenring; Gregory Y Lauwers; Young-Kee Shin; Jason C Mills
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

3.  Seminal vesicle involvement by urothelial carcinoma in situ of the bladder with mucosal spread pattern: a case report.

Authors:  Song-Yi Choi; Ho-Chang Lee; Hyung Geun Song; Wun-Jae Kim; Ok-Jun Lee
Journal:  Korean J Urol       Date:  2012-05-18

Review 4.  The pathology of urinary bladder lesions with an inverted growth pattern.

Authors:  Aitao Guo; Aijun Liu; Xiaodong Teng
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

5.  Histopathological spectrum of 364 prostatic specimens including immunohistochemistry with special reference to grey zone lesions.

Authors:  Monika Garg; Gurmeen Kaur; Vineeta Malhotra; Ravish Garg
Journal:  Prostate Int       Date:  2013-12-30

6.  Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy.

Authors:  Julian Arista-Nasr; Braulio Martinez-Benitez; Leticia Bornstein-Quevedo; Elizmara Aguilar-Ayala; Claudia Natalia Aleman-Sanchez; Raul Ortiz-Bautista
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.